
Clinical Trials - The Expanding Landscape of Regenerative Medicine
Description
Clinical Trials - The Expanding Landscape of Regenerative Medicine
Summary
This report provides an overview of global regenerative medicine clinical trials and an analysis of any trends through the years.
Scope
Summary
This report provides an overview of global regenerative medicine clinical trials and an analysis of any trends through the years.
Scope
- The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data was captured in the database as of September 8, 2022. The data has been analyzed by trial start year, phase, status, sponsor type, geography, single-country vs. multinational, virtual components, therapy area, indication, reasons for discontinuation, endpoint status, sponsors, and drugs.
- Trends of regenerative medicine trials through the years
- Comparison of trials by sponsor type
- Can view top therapy areas, indications, geographies and sponsors
- Focus on the usage of decentralized clinical trials/virtual components
- Analysis of top drugs used
Table of Contents
30 Pages
- Executive Summary
- Introduction
- The Expanding Landscape of Regenerative Medicine
- 2020 Has the Most Regenerative Medicine Clinical Trials
- Phase II Trials Top Regenerative Medicine Trials
- Industry-Sponsored Trials Dominate
- North America and the US Saw the Most Trials
- North America Has the Most Single-Country Trials While Europe Has the Most Multinational
- Virtual Components Used Less in Regenerative Medicine Clinical Trials
- Cardiovascular Is the Most Researched Therapy Area
- Low Accrual Rate Is the Leading Cause of Trial Termination
- Phase II and Industry-Sponsored Trials Achieved Their Endpoints More Frequently
- Mesoblast Is the Top Industry Sponsor
- Foundation for Orthopedics and Regenerative Medicine Is the Top Non-industry Sponsor
- Tisagenlecleucel Is the Top Drug Used in Regenerative Medicine Clinical Trials
- Key Findings
- Appendix
- List of Figures
- Figure 1: Number of regenerative medicine clinical trials, by trial start year
- Figure 2: Regenerative medicine clinical trials, by phase and status
- Figure 3: Number of regenerative medicine clinical trials, by sponsor type and year
- Figures
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.